Found 10 matching trials
A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
PHASE1An Open-Label Study in Healthy Male and Female Subjects to Identify the Con...
Location
Quotient Clinical LTD
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations
PHASE3To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) exte...
Location
Xenoscience, Inc. (102)
Augmenting Language Therapy for Aphasia: Levodopa
PHASE2The purpose of this study is to evaluate the effectiveness of the medicatio...
Location
Center for Aphasia Research & Treatment
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
PHASE3This is a study to compare the efficacy of IPX066 and CLE in subjects with ...
Location
Margolin Brain Institute
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
PHASE2This study evaluated the pharmacokinetics, motor effects, and assessed the ...
Location
IMPAX Laboratories
Comparison of IPX054, IR Carbidopa-Levodopa, and CR Carbidopa-Levodopa in Subjects With Parkinson's Disease
PHASE2The objective of this study is to compare the pharmacokinetics and pharmaco...
Location
Quest Research Institute
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
PHASE2The purpose of the study is to assess the efficacy and safety of XP21279/Ca...
Location
XenoPort Clinical Site
Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
PHASE2This is a 6-month double-blinded, randomized, placebo-controlled clinical t...
Location
Second Affiliated Hospital of Wenzhou Medical University
Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study
PHASE4To find out if a single dose of Parcopa®, a form of levodopa that dissolves...
Location
PDCMDC 6550 Fannin, Suite 1801
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
PHASE3This is a study to evaluate the safety and efficacy of IPX066 in advanced P...